Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flurbiprofen micro granules for sore throat due to upper respiratory infection
ACTRN12609000329268Phase 3Completed
- Sponsor
- Reckitt
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in upper respiratory infection (URI) and pharyngitis comparing Flurbiprofen micro granules with Placebo micro granules (2 arms). Primary endpoint: AUC in change from baseline in throat soreness from 0 to 2 hours. Started May 2009; status: completed.
02
Drugs
flurbiprofen
03
Conditions
upper respiratory infection (URI)pharyngitis
Beyond the preview
Go deeper on ACTRN12609000329268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000329268.